https://www.worldpharmatoday.com/press-releases/sarepta-therapeutics-gazes-fda-approval-of-golodirsen-srp-4053-in-patients-with-duchenne-muscular-dystrophy-dmd-amenable-to-skipping-exon-53/ Magazine for the C-level Pharma Executives Mon, 19 Mar 2018 00:56:39 +0000 hourly 1 https://wordpress.org/?v=6.9.4